Neuren Pharmaceuticals Limited (NURPF)
Market Closed
10 Aug, 20:00
OTC PINK 
$
16. 00
+1
+6.6667%
$
1.12B Market Cap
- P/E Ratio
- Div Yield
4,450 Volume
- Eps
$ 15
Previous Close Want to track NURPF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neuren Pharmaceuticals Limited (NURPF) Statistics
Valuation metrics
Market Cap 1.12B
Enterprise value 2.88B
Trailing P/E (ttm) 94.67
Forward P/E -
PEG ratio -1.21
Price/Sales (ttm) 44.56
Price/Book (mrq) 8.5
Enterprise Value/Revenue 44.5
Enterprise Value/EBITDA 130.45
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 300
Average volume (90 days) 146
Price summary
52-Week low 7.7
52-Week high 16
Beta -
50-Day moving average 12.7
200-Day moving average 10.04
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 21 Nov 2017
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.47%
Operating margin 0.11%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.09%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.51
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.24
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.34
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 76.6%
Book value per share (mrq) 2.67
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
